HOME >> BIOLOGY >> NEWS
Elevated CO2 in atmosphere weakens defenses of soybeans to herbivores

In research to be presented at the annual meeting of the American Society of Plant Biologists in Chicago (July 7-11, 2007), scientists will show that elevated CO2 may negatively impact the relationship between some plants and insects. Elevated CO2 is considered to be a serious catalyst of global change. Its effects can be felt throughout the ecosystem, including the insect-plant food chain link. Safeguarding highly-usable crops is of great importance to many local and national economies.

Many plants have inherent enzyme-based defenses that are released during insect attack. This study found that when soybeans (Glycine max) were exposed to elevated amounts of CO2 the plants became more susceptible to attack by Japanese beetles (Popillia japonica). Furthermore, as these beetles consumed the weakened soybeans, the insects invasive abilities were intensified.

Dr. Jorge Zavala, Sr. of the Institute for Genomic Biology at the University of Illinois, and his colleagues conducted tests in which they evaluated this herbivorous attack-defense cycle. They studied soybeans grown in traditional field conditions but with additional exposure to ambient CO2. The results showed that the amount of cysteine proteinase inhibitors (CystPls) expressed in the genes decreased when soybeans were exposed to elevated CO2. CystPls is naturally produced by soybeans when they are under insect attack. It inhibits further attack once the invader has ingested it.

Our results suggest that elevated CO2 increased the susceptibility of soybean to invasive insects by down-regulating the expression of hormones related with defense, which down-regulate the important defense CystPls against beetles, Zavala said.

Zavala also explained, Under natural field conditions, elevated CO2 not only increased susceptibility of soybean to herbivory by the invasive species Japanese beetle, but also enhanced the performance of these beetles.

The investigatio
'"/>

Contact: Brian Hyps
bhyps@aspb.org
240-354-5160
American Society of Plant Biologists
6-Jul-2007


Page: 1 2

Related biology news :

1. Elevated autoantibodies linked to preeclampsia
2. Elevated atmospheric CO2 increases soil carbon
3. Elevated temperature enhances success of viral cancer therapy
4. Elevated inflammatory enzyme, Lp-PLA2, significantly linked to ischemic stroke
5. Bacterial switch gene regulates how oceans emit sulfur into atmosphere
6. Tropical forests leak nitrogen back into atmosphere, say scientists
7. Mercury in atmosphere could be washed out more easily than earlier believed
8. Methane gyrations last 2,000 years show human influnece on atmosphere
9. U. of Colorado study shows early Earth atmosphere hydrogen-rich, favorable to life
10. Epilepsy drug eases symptoms of inherited disorder that weakens muscles
11. Aggression-related gene weakens brains impulse control circuits

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Elevated atmosphere weakens defenses soybeans herbivores

(Date:6/30/2015)... 30, 2015 Genisphere announced ... to help further develop Genisphere,s therapeutics capabilities and portfolio. ... having spent much of the last 25 years in ... Bioscience, and Johnson & Johnson. Tom started his career ... Biotech Corporate Finance. He graduated from Dartmouth College with ...
(Date:6/26/2015)... 26, 2015 ATL Technology, LLC, a top provider ... in single use solutions, headquartered in Springville, Utah ... California corporation with locations in ... Jose, Costa Rica ). This acquisition will ... with ATL Technology,s existing facility in Costa ...
(Date:6/25/2015)... , June 25, 2015  Imagine a tool specifically ... a healthier, happier life. That,s exactly what USANA,s ... do. The cutting-edge, portable health program provides a personalized ... to help improve your lifestyle and nutrition. ... and gala Wednesday night, USANA,s THA was honored with ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
(Date:7/2/2015)... , ... July 02, 2015 , ... ... and manufacturing of surgical instruments in Orthopedics, announced today the acquisition of ... the world's largest provider of surgical instruments to the Spine Industry. The acquisition ...
(Date:7/1/2015)... , July 1, 2015   Decision Resources ... cited advantages of Otezla are its oral administration, ... as reported by surveyed rheumatologists. Otezla was the ... the treatment of active psoriatic arthritis in ... standard of care includes conventional oral treatments including ...
(Date:7/1/2015)... ALTO, Calif. , July 1, 2015 /PRNewswire/ ... focused on the development of groundbreaking drugs to ... (ALS), announced today that Robert G. Miller ... Center at Sutter Health,s California Pacific Medical Center ... The ALS Association for $1.5 million to help ...
(Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business ... to lower the barriers to innovation in life sciences R&D. The Pistoia Alliance President’s ... cash prizes of US$15,000 and a period of expert mentorship from a senior industry ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
Cached News: